Center-Authored Papers

Filters: Author is Hsia, Judith  [Clear All Filters]
Journal Article
Katayama H, Paczesny S, Prentice RL, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J et al..  2009.  Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings.. Genome medicine. 1(4):47. Abstract
Allison MA, Manson JE, Langer RD, Aragaki A, Smoller S, Lewis CE, Thomas A, Lawson W, Cochrane BB, Hsia J et al..  2008.  Association between different measures of blood pressure and coronary artery calcium in postmenopausal women.. Hypertension. 52(5):833-40. Abstract
Manson JE, Allison MA, Carr JJ, Langer RD, Cochrane BB, Hendrix SL, Hsia J, Hunt JR, Lewis CE, Margolis KL et al..  2010.  Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative.. Menopause (New York, N.Y.). 17(4):683-91. Abstract
Rossouw J, Bray P, Liu J, Kooperberg C, Hsia J, Lewis C, Cushman M, Bonds D, Hendrix S, Papanicolaou G et al..  2011.  Estrogen receptor polymorphisms and the vascular effects of hormone therapy.. Arteriosclerosis, thrombosis, and vascular biology. 31(2):464-9. Abstract
Hsia J, Rodabough RJ, Manson JE, Liu S, Freiberg MS, Graettinger W, Rosal MC, Cochrane BB, Lloyd-Jones D, Robinson JG et al..  2010.  Evaluation of the American Heart Association cardiovascular disease prevention guideline for women.. Circulation. Cardiovascular quality and outcomes. 3(2):128-34. Abstract
Rossouw JE, Cushman M, Greenland P, Lloyd-Jones DM, Bray P, Kooperberg C, Pettinger M, Robinson J, Hendrix S, Hsia J.  2008.  Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.. Archives of internal medicine. 168(20):2245-53. Abstract
Wassertheil-Smoller S, Kooperberg C, McGinn AP, Kaplan RC, Hsia J, Hendrix SL, Manson JE, Berger JS, Kuller LH, Allison MA et al..  2008.  Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.. Hypertension. 51(4):1115-22. Abstract
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ et al..  2013.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.. JAMA : the journal of the American Medical Association. 310(13):1353-68. Abstract
Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh MW, Wang P, Buson Busald T, Hsia J et al..  2010.  Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling.. Genome medicine. 2(7):48. Abstract
Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, Phillips L, Cochrane BB, Eaton CB, Greenland P et al..  2008.  Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study.. Menopause (New York, N.Y.). 15(4 Pt 1):639-47. Abstract
Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM et al..  2009.  Postmenopausal estrogen and progestin effects on the serum proteome.. Genome medicine. 1(12):121. Abstract
Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM.  2013.  Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.. Genome medicine. 5(12):112. Abstract
Rossouw JE, Prentice RL, Manson JE, Aragaki AK, Hsia J, Martin LW, Kuller L, Johnson KC, Eaton C, Jackson R et al..  2012.  Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.. Circulation. 126(13):1577-86. Abstract